So the issue is your purchase price, not the company. For perspective:
Column 1 Column 2 Column 3 0 Company Last 6 months revenue Market Cap 1 Eden Innovations $468,000 $195.4mn 2 Structural Monitoring $302,705 $133.2mn 3 Emefcy $488,236 $358.0mn 4 Aurora Labs $52,783 $148.5mn 5 Combined Total $1,311,724 $835.1mn 6 7 CFOAM $706,154* $35.5mn
* 10 weeks only.
Annualising CFOAM for a full 6 month period, would yield a revenue number of $1,836,000. That is, CFOAM, after 10 weeks, is making 40% more revenue than all of its comps COMBINED. Its market cap is 4% of the combined total and 25% of the smallest comp. 75% of production went into inventory and there was close to $500k in one-offs...and overheads are less than $2mn annualised...
Honestly, its no wonder management don't want to talk to most of you. They'd lose brain cells the moment they said hello to a lot of you people.
- Forums
- ASX - By Stock
- Ann: Half Year Report and Appendix 4D
So the issue is your purchase price, not the company. For...
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CFO (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.468M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
CFO (ASX) Chart |
Day chart unavailable